Medicare Negotiation Process Remains Largely Unchanged

 
• By Michael McCaughan
  
The key elements for selecting drugs for Medicare price negotiation did not change in the latest guidance. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from United States